Profil
Nancy Sacco is a former Head of Clinical Development at AnaptysBio, Inc. and a former Vice President and Head of Clinical Development at Xentria, Inc. She also served as the Chief Development Officer at Hexima Ltd.
in 2021-2022.
Sacco holds a doctorate degree from West Virginia University School of Medicine.
Ehemalige bekannte Positionen von Nancy Sacco
| Unternehmen | Position | Ende |
|---|---|---|
| HEXIMA LIMITED | Corporate Officer/Principal | 15.10.2022 |
Xentria, Inc.
 Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Chief Tech/Sci/R&D Officer | - |
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Nancy Sacco
| West Virginia University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| HEXIMA LIMITED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Health Technology |